These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 2298369)

  • 21. Complete elimination of reflux symptoms does not guarantee normalization of intraesophageal acid reflux in patients with Barrett's esophagus.
    Ouatu-Lascar R; Triadafilopoulos G
    Am J Gastroenterol; 1998 May; 93(5):711-6. PubMed ID: 9625114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine therapy in patients with idiopathic gastric acid hypersecretion. A prospective study.
    Collen MJ; Wirshup JF
    Dig Dis Sci; 1995 Aug; 40(8):1687-90. PubMed ID: 7648968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bleeding duodenal ulcer. Role of gastric acid hypersecretion.
    Collen MJ; Kalloo AN; Sheridan MJ
    Dig Dis Sci; 1993 Feb; 38(2):269-75. PubMed ID: 8093870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ranitidine and cisapride on acid reflux and oesophageal motility in patients with reflux oesophagitis: a 24 hour ambulatory combined pH and manometry study.
    Inauen W; Emde C; Weber B; Armstrong D; Bettschen HU; Huber T; Scheurer U; Blum AL; Halter F; Merki HS
    Gut; 1993 Aug; 34(8):1025-31. PubMed ID: 8174947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patterns of gastroesophageal reflux in health and disease.
    Demeester TR; Johnson LF; Joseph GJ; Toscano MS; Hall AW; Skinner DB
    Ann Surg; 1976 Oct; 184(4):459-70. PubMed ID: 13747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Time pattern of gastric acidity in Barrett's esophagus.
    Savarino V; Mela GS; Zentilin P; Mele MR; Mansi C; Remagnino AC; Vigneri S; Malesci A; Belicchi M; Lapertosa G; Celle G
    Dig Dis Sci; 1996 Jul; 41(7):1379-83. PubMed ID: 8689914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alkaline gastroesophageal reflux: implications in the development of complications in Barrett's columnar-lined lower esophagus.
    Attwood SE; DeMeester TR; Bremner CG; Barlow AP; Hinder RA
    Surgery; 1989 Oct; 106(4):764-70. PubMed ID: 2799652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.
    Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
    Dig Dis Sci; 2002 Feb; 47(2):265-73. PubMed ID: 11855540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prevalence of Helicobacter pylori infection and the status of gastric acid secretion in patients with Barrett's esophagus in Japan.
    Abe Y; Ohara S; Koike T; Sekine H; Iijima K; Kawamura M; Imatani A; Kato K; Shimosegawa T
    Am J Gastroenterol; 2004 Jul; 99(7):1213-21. PubMed ID: 15233656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Symptoms, acid exposure and motility in patients with Barrett's esophagus.
    Brandt MG; Darling GE; Miller L
    Can J Surg; 2004 Feb; 47(1):47-51. PubMed ID: 14997925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of pyrosis does not insure adequate control of gastric acid reflux.
    Collen MJ; Strong RM
    Am J Gastroenterol; 1995 Apr; 90(4):672-3. PubMed ID: 7717342
    [No Abstract]   [Full Text] [Related]  

  • 32. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
    Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
    Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time of administration influences gastric inhibitory effects of ranitidine.
    Johnston DA; Wormsley KG
    Scand J Gastroenterol; 1988 Nov; 23(9):1137-40. PubMed ID: 3247592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
    Triadafilopoulos G; Kaczynska M; Iwane M
    Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical dysphagia is associated with gastric hyperacidity.
    Singh S; Hinder RA; Naspetti R; Jamieson JR; Polishuk PV; DeMeester TR
    J Clin Gastroenterol; 1993 Mar; 16(2):98-102. PubMed ID: 8463631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ineffective esophageal motility and gastroesophageal reflux disease: a close relationship?
    Ergün M; Doğan İ; Ünal S
    Turk J Gastroenterol; 2012; 23(6):627-33. PubMed ID: 23794296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Investigation of ranitidine 150 mg bd or 300 mg bd in the treatment of reflux disease.
    Schaub N; Meyrick Thomas J; Misiewicz JJ; Lovell D; Trotman IF
    Hepatogastroenterology; 1986 Oct; 33(5):208-13. PubMed ID: 3804176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastric acid and pepsin secretion in patients with Barrett's esophagus and appropriate controls.
    Hirschowitz BI
    Dig Dis Sci; 1996 Jul; 41(7):1384-91. PubMed ID: 8689915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux.
    Achem SR; Kolts BE; Wears R; Burton L; Richter JE
    Am J Gastroenterol; 1993 Feb; 88(2):187-92. PubMed ID: 8424418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.